Pages that link to "Q48401641"

The following pages link to Does natalizumab therapy worsen neuromyelitis optica? (Q48401641):

Displaying 39 items.

• MRI characteristics of neuromyelitis optica spectrum disorder: an international update (Q28087067) (← links)
• MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome (Q30371412) (← links)
• [Ultrahigh field MRI in context of neurological diseases]. (Q30759627) (← links)
• Neuromyelitis optica: clinical features, immunopathogenesis and treatment. (Q30785267) (← links)
• Systemic Lupus Erythematosus (SLE) Complicated by Neuromyelitis Optica (NMO - Devic's Disease): Clinic-Pathological Report and Review of the Literature (Q33734731) (← links)
• Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS. (Q33808279) (← links)
• Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis (Q34785270) (← links)
• Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). (Q35052199) (← links)
• Unmasking and provoking severe disease activity in a patient with NMO spectrum disorder (Q35105745) (← links)
• Neuromyelitis optica (NMO) and autoimmune thyroiditis (Q36226577) (← links)
• Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders (Q36484394) (← links)
• Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases? (Q36648907) (← links)
• Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes. (Q36753462) (← links)
• Evaluation of aquaporin-4 antibody assays. (Q37404328) (← links)
• Immunotherapy of neuromyelitis optica (Q37456974) (← links)
• Treating neuromyelitis optica with the interleukin-6 receptor antagonist tocilizumab (Q37684228) (← links)
• "Bright spotty lesions" on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis (Q38119474) (← links)
• Neuromyelitis optica spectrum disorders. (Q38229823) (← links)
• Overlapping CNS inflammatory diseases: differentiating features of NMO and MS. (Q38253493) (← links)
• Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal (Q38534132) (← links)
• Therapeutic options in neuromyelitis optica spectrum disorders (Q38721559) (← links)
• Natalizumab in relapsing-remitting multiple sclerosis (Q38786252) (← links)
• What's new in neuromyelitis optica? A short review for the clinical neurologist (Q39176987) (← links)
• Neuromyelitis optica presenting with relapses under treatment with natalizumab: a case report (Q40342983) (← links)
• Longitudinally extensive myelitis in MS mimicking neuromyelitis optica (Q42321388) (← links)
• Therapeutic options for autoimmune encephalomyelitis (Q43607388) (← links)
• The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders (Q44061291) (← links)
• Life on hold: the experience of living with neuromyelitis optica (Q44299516) (← links)
• Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica (Q44973372) (← links)
• Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorder (Q47924759) (← links)
• Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients. (Q48954062) (← links)
• Practice current: How do you treat neuromyelitis optica? (Q49556620) (← links)
• Natalizumab and the development of extensive brain lesions in neuromyelitis optica (Q50951718) (← links)
• Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. (Q51036839) (← links)
• A prospective case-control study comparing optical coherence tomography characteristics in neuromyelitis optica spectrum disorder- optic neuritis and idiopathic optic neuritis (Q58741638) (← links)
• Neuromyelitis optica spectrum disorders (Q64075567) (← links)
• Pediatric Neuromyelitis Optica Spectrum Disorders (Q88551231) (← links)
• The clinical profile of NMOSD in Australia and New Zealand (Q89476358) (← links)
• Hindsight is 20/20 (Q89969569) (← links)